English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In the USA, the MitraClip is still considered an investigational device, under continued access policy, following the completion of the EVEREST II (Endovascular Valve Edge-to-Edge REpair Study) randomized control trial comparing mitral valve repair using the MitraClip vs. surgery. About 50 centres in Europe have been using the technique since September 2008, and 2 years later, 1000 procedures have been performed. The rate of implants in Europe is accelerating, and in September 2010, around 100 patients were being treated per month. The issue now is how to incorporate the MitraClip technique alongside the standard treatment of mitral disease, which is surgical valve repair or replacement.

european heart journal

CardioPulse Articles * The percutaneous approach to mitral valve repair * The future treatment of most cardiovascular diseases lies in percutaneous interventional techniques * Information for all: the American Heart Association * Personal experiences of emigre cardiologist: Johannes Waltenberger